Showing results (91-100 of 264) with videos related to

Sort By:
Pageof 27
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 23, 2012
Fluticasone furoate nasal spray reduces symptoms of uncomplicated acute rhinosinusitis: a randomised placebo-controlled studyPaul K Keith, Andrzej Dymek, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology|September 16, 2015
Sublingual grass and ragweed immunotherapy: Clinical considerations-a PRACTALL consensus reportJames T Li, David I Bernstein, Moises A Calderon, et al.
The Laryngoscope|October 12, 2022
Phytomedicine ELOM-080 in Acute Viral Rhinosinusitis: A Randomized, Placebo-Controlled, Blinded Clinical TrialOliver Pfaar, Achim G Beule, Detmar Jobst, et al.
The Journal of Allergy and Clinical Immunology. Global|November 18, 2024
A RESPONSE to anti-IL-5 therapy in comorbid patients with chronic rhinosinusitis with nasal polyps and severe asthma: Study protocolPetros Bakakos, Isam Alobid, Jannis Constantinidis, et al.
Allergy|July 27, 2021
One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidenceOliver Pfaar, Jean Bousquet, Stephen R Durham, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 18, 2018
Comparison of International Systemic Adverse Reactions Due to Allergen ImmunotherapyCarmen Vidal, Pablo Rodríguez Del Río, Francisco Gude, et al.
Journal of Personalized Medicine|May 27, 2023
Mechanisms of Allergen Immunotherapy and Potential Biomarkers for Clinical EvaluationUmit M Sahiner, Mattia Giovannini, Maria M Escribese, et al.
Clinical and Translational Allergy|July 10, 2026
Between Guidelines and Daily Practice: The Persistent Use of Parenteral Depot Corticosteroids in GermanyChristian Taube, Timm Greulich, Sebastian Böing, et al.
Clinical and Translational Allergy|September 22, 2017
Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA2LEN studyGeorg Boelke, Uwe Berger, Karl-Christian Bergmann, et al.
Allergy|November 4, 2024
The SQ tree sublingual immunotherapy tablet is effective and well tolerated in children-A pivotal phase III trialMonika Gappa, Rémi Gagnon, Fritz Horak, et al.
Pageof 27